Journal article
Long-term hospitalisation rates among 5-year survivors of Hodgkin Lymphoma in adolescence or young adulthood - A nationwide cohort study.
- Abstract:
- In the present study, we report on the full range of physical diseases acquired by survivors of Hodgkin lymphoma diagnosed in adolescence or young adulthood. In a Danish nationwide population-based cohort study, 1768 five-year survivors of Hodgkin lymphoma diagnosed at ages 15–39 years during 1943-2004 and 228,447 comparison subjects matched to survivors on age and year of birth were included. Hospital discharge diagnoses and bed-days during 1977-2010 were obtained from the Danish Patient Register for 145 specific disease categories gathered in 14 main diagnostic groups. The analysis was conducted separately on three sub-cohorts of survivors, i.e. survivors diagnosed 1943-1976 for whom we had no information on re-hospitalisation for Hodgkin lymphoma and survivors diagnosed 1977-2004, split into a subcohort with no expected relapses and a subcohort for whom a re-hospitalisation for Hodgkin lymphoma indicated a relapse. The overall standardised hospitalisation rate ratios (RRs) were 2.0 (95% confidence interval (CI), 1.9-2.1), 1.5 (1.4-1.6) and 2.9 (2.6-3.1) respectively, and the corresponding RRs for bed-days were 3.5 (3.4-3.5), 1.8 (1.8-1.9) and 10.4 (10.3-10.6). Highest RRs were seen for non-malignant haematological conditions (RR: 2.6; 3.1 and 9.7), malignant neoplasms (RR: 3.2; 2.5 and 4.7) and all infections combined (RR: 2.5; 2.2 and 5.3). Survivors of Hodgkin lymphoma in adolescence or young adulthood are at increased risk for a wide range of diseases that require hospitalisation. The risk depends on calendar period of treatment and on whether the survivors were re-hospitalised for Hodgkin lymphoma, and thus likely had a relapse.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 576.3KB, Terms of use)
-
- Publisher copy:
- 10.1002/ijc.30655
Authors
+ Cancer Research UK
More from this funder
- Funding agency for:
- Aznar, M
- Cutter, D
- Darby, S
- Grant:
- C8225/A21133
- C8225/A21133
- C8225/A21133
- Publisher:
- Wiley
- Journal:
- International Journal of Cancer More from this journal
- Volume:
- 140
- Issue:
- 10
- Pages:
- 2232–2245
- Publication date:
- 2017-02-01
- Acceptance date:
- 2017-02-02
- DOI:
- ISSN:
-
1097-0215
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:681357
- UUID:
-
uuid:674999ef-3b50-40e2-8083-c46a55503f89
- Local pid:
-
pubs:681357
- Deposit date:
-
2017-03-01
- ARK identifier:
Terms of use
- Copyright holder:
- Aznar et al
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors. International Journal of Cancer published by John Wiley and Sons Ltd on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record